Johnson & Johnson (JNJ) Income towards Parent Company (2009 - 2026)

Johnson & Johnson (JNJ) posted Income towards Parent Company of $5.2 billion for Q1 2026, up 2.33% sequentially from $5.1 billion in Q4 2025, and down 52.4% YoY from $11.0 billion in Q1 2025.

Johnson & Johnson (JNJ) Income towards Parent Company (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 17 years of Income towards Parent Company data on file, last reported at $5.2 billion in Q1 2026.

  • Quarterly Income towards Parent Company fell 52.4% year-over-year to $5.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.0 billion (up 91.29% YoY) and the FY2023 annual result came in at $21.8 billion, up 1289.37% from the prior year.
  • Income towards Parent Company rose to $5.2 billion in Q1 2026 per JNJ's latest filing, from $5.1 billion in the prior quarter.
  • The five-year high for Income towards Parent Company was $21.7 billion in Q4 2023, with the low at -$232.0 million in Q3 2023.
  • Average Income towards Parent Company over 4 years is $4.3 billion, with a median of $578.0 million recorded in 2022.
  • The widest YoY moves for Income towards Parent Company: up 14575.0% in 2023, down 142.03% in 2023.
  • Johnson & Johnson's Income towards Parent Company stood at $148.0 million in 2022, then sank by 156.08% to -$83.0 million in 2023, then jumped by 6263.86% to $5.1 billion in 2025, then gained by 2.33% to $5.2 billion in 2026.
  • Business Quant data shows JNJ's Income towards Parent Company at $5.2 billion in Q1 2026, $5.1 billion in Q4 2025, and $5.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 5.24 Bn
Dec 28, 2025 5.12 Bn
Sep 28, 2025 5.15 Bn
Jun 29, 2025 5.54 Bn
Mar 30, 2025 11.00 Bn
Dec 31, 2023 -83.00 Mn
Oct 1, 2023 21.72 Bn
Jul 2, 2023 -232.00 Mn
Apr 2, 2023 423.00 Mn
Jan 1, 2023 293.00 Mn
Oct 2, 2022 148.00 Mn
Jul 3, 2022 552.00 Mn
Apr 3, 2022 578.00 Mn
Oct 3, 2021 3.67 Bn
Jul 4, 2021 6.28 Bn
Apr 4, 2021 6.20 Bn
Jan 3, 2021 1.74 Bn
Sep 27, 2020 3.55 Bn
Jun 28, 2020 3.63 Bn
Mar 29, 2020 5.80 Bn